Comparison of components profile in herbal raw material, extract and pharmaceuticals of Hedera Helix

Authors

DOI:

https://doi.org/10.15587/2519-4852.2020.210768

Keywords:

ivy leaf, components profile, pharmaceuticals, extracts, HPLC

Abstract

The aim. To investigate both the profile of components and possible difference among herbal raw materials, semi-products and pharmaceuticals of Hedera helix for determination of main standartisation markers.

Materials and methods. Investigation of components profile has been performed using the Shimadzu Nexera X2 chromatographic system coupled with a diode-area detector. The ACE C 18 column (250 mm × 4.6 mm with particle size 5 mm) was used for the separation of components. 0.1 % acetic acid and acetonitrile were used as mobile phase A and B, respectively. Studies have been performed on the leaves, dry extract and capsules of H. helix.

Results. The determined profile had no significant variation among samples. It has been presented by 19 various components, such as phenolic acids, flavonoids and triterpene saponins. However, kaempferol, nicotiflorin and t-cinnamic acid were not found in the leaf raw material. Hederacoside C might be highlighted as the main marker of raw materials and products of H. helix due to its significant amount in comparison to other components. Its amount was in the range of 64,80 % up to 71,46 % of the total content of components. Moreover, according to some pharmacological studies, hederacoside C is responsible for pharmaceutical usage of H. helix pharmaceutics. Nevertheless, it is not recommended to standardize the plant-based medicines by one marker, since the pharmaceutical activity of such dosage forms is defined by synergism action of all constituents. Except for hederacoside C significant amounts in comparison to other components were found for chlorogenic acid and 4,5-dicaffeoylquinic acid about 5 % and 3 % respectively. Though the latter was found in small concentrations in leaves (0,058 %). This sample had a much higher amount of 3,5-dicaffeoylquinic acid, but in the case of extract and capsules, its content was lower 1,55 % and 0,66 % respectively. Thus, chlorogenic acid has been chosen as a second marker due to its high concentration in all samples and some pharmaceutical activities, such as antioxidant and anti-inflammatory effects.

Conclusions. It was found, that standartisation of H. helix products is preferably to perform with determination both hederacoside C and chlorogenic acid. These components were dominant among all components; besides they possess a wide range of pharmaceutical effects. Hence, quantification of hederacoside C and chlorogenic acid is necessary to ensure the high quality of H. helix pharmaceuticals.

Author Biographies

Ivan Bezruk, National University of Pharmacy Pushkinska str., 53, Kharkiv, Ukraine, 61002

Postgraduate student

Department of Pharmaceutical Chemistry

Victoriya Georgiyants, National University of Pharmacy Pushkinska str., 53, Kharkiv, Ukraine, 61002

Doctor of Pharmaceutical Sciences, Professor, Head of Department

Department of Pharmaceutical Chemistry

Liudas Ivanauskas, Lithuanian University of Health Sciences Mickevičiaus g. 9, Kaunas, Lithuania, LT 44307

Doctor of Biomedical Sciences, Professor, Head of Department

Department of Analytical and Toxicological Chemistry

References

  1. Obiageri, O. (2012). Pharmacokinetics and Drug Interactions of Herbal Medicines: A Missing Critical Step in the Phytomedicine/Drug Development Process. Readings in Advanced Pharmacokinetics – Theory, Methods and Applications. doi: http://doi.org/10.5772/33699
  2. Tistaert, C., Dejaegher, B., Heyden, Y. V. (2011). Chromatographic separation techniques and data handling methods for herbal fingerprints: A review. Analytica Chimica Acta, 690 (2), 148–161. doi: http://doi.org/10.1016/j.aca.2011.02.023
  3. Guo, D. (2017). Quality Marker Concept Inspires the Quality Research of Traditional Chinese Medicines. Chinese Herbal Medicines, 9 (1), 1–2. doi: http://doi.org/10.1016/s1674-6384(17)60069-8
  4. Edeoga, H. O., Okwu, D. E., Mbaebie, B. O. (2005). Phytochemical constituents of some Nigerian medicinal plants. African Journal of Biotechnology, 4 (7), 685–688. doi: http://doi.org/10.5897/ajb2005.000-3127
  5. Muthuselvam, S. A. (2009). Analysis of phytochemical constituents and antimicrobial activities of aloe vera L. against clinical pathogens. World Journal of Agriculture and Soil Science, 5 (5), 572–576.
  6. European Pharmacopoeia (2019). Available at: https://www.edqm.eu/en/european-pharmacopoeia-ph-eur-10th-edition
  7. Derzhavna Pharmakopeya Ukrayini. Vol. 1. DP «Naukovo-ekspertniy farmakopeyniy tsentr» (2015). Kharkiv: DP «Ukrayinskiy naukoviy farmakopeyniy tsentr yakostI lIkarskih zasobIv», 1128.
  8. Bezruk, I., Kotvitska, A., Korzh, I., Materiienko, A., Gubar, S., Budanova, L. et. al. (2020). Combined Approach to the Choice of Chromatographic Methods for Routine Determination of Hederacoside C in Ivy Leaf Extracts, Capsules, and Syrup. Scientia Pharmaceutica, 88 (2), 24. doi: http://doi.org/10.3390/scipharm88020024
  9. Glushchenko, A., Bezruk, I., Bevz, N., Ivanauskas, L., Georgiyants, V. (2019). Development of the procedure of quantitative determination of the biological active substances in the extract of a bupleurum aureum in the composition of a combined dosage form. ScienceRise: Pharmaceutical Science, 1 (17), 11–16. doi: http://doi.org/10.15587/2519-4852.2019.157947
  10. Mykhailenko, O., Gudžinskas, Z., Kovalyov, V., Desenko, V., Ivanauskas, L., Bezruk, I., Georgiyants, V. (2020). Effect of ecological factors on the accumulation of phenolic compounds in Iris species from Latvia, Lithuania and Ukraine. Phytochemical Analysis, 31 (5), 545–563. doi: http://doi.org/10.1002/pca.2918
  11. Bezruk, I., Marksa, M., Georgiyants, V., Ivanauskas, L., Raudone, L. (2020). Phytogeographical profiling of ivy leaf (Hedera helix L.). Industrial Crops and Products, 154, 112713. doi: http://doi.org/10.1016/j.indcrop.2020.112713
  12. Greunke, C., Hage-Hülsmann, A., Sorkalla, T., Keksel, N., Häberlein, F., Häberlein, H. (2015). A systematic study on the influence of the main ingredients of an ivy leaves dry extract on the β2-adrenergic responsiveness of human airway smooth muscle cells. Pulmonary Pharmacology & Therapeutics, 31, 92–98. doi: http://doi.org/10.1016/j.pupt.2014.09.002
  13. Schmidt, O. (2003). Biopharmazeutische Charakterisierung von Efeublattertrockenextrakten durch in vivo und in vitro Studien (Dissertation). Heidelberg: Ruprecht-Karls-Universiat.
  14. Naveed, M., Hejazi, V., Abbas, M., Kamboh, A. A., Khan, G. J., Shumzaid, M. et. al. (2018). Chlorogenic acid (CGA): A pharmacological review and call for further research. Biomedicine & Pharmacotherapy, 97, 67–74. doi: http://doi.org/10.1016/j.biopha.2017.10.064
  15. Kim, H.-R., Lee, D.-M., Lee, S.-H., Seong, A.-R., Gin, D.-W., Hwang, J.-A., Park, J.-H. (2010). Chlorogenic acid suppresses pulmonary eosinophilia, IgE production, and Th2-type cytokine production in an ovalbumin-induced allergic asthma: Activation of STAT-6 and JNK is inhibited by chlorogenic acid. International Immunopharmacology, 10 (10), 1242–1248. doi: http://doi.org/10.1016/j.intimp.2010.07.005
  16. Yu, M., Shin, Y. J., Kim, N., Yoo, G., Park, S., Kim, S. H. (2014). Determination of Saponins and Flavonoids in Ivy Leaf Extracts Using HPLC-DAD. Journal of Chromatographic Science, 53 (4), 478–483. doi: http://doi.org/10.1093/chromsci/bmu068
  17. Demirci, B., Goppel, M., Demirci, F., Gerhard, F. (2004). HPLC profiling and quantification of active principles in leaves of Hedera helix L. Die Pharmazie, 59, 770–774.
  18. Khdair, A., Mohammad, M. K., Tawaha, K., Al-Hamarsheh, E., AlKhatib, H. S., Al-khalidi Bashar et. al. (2010). A Validated RP HPLC-PAD Method for the Determination of Hederacoside C in Ivy-Thyme Cough Syrup. International Journal of Analytical Chemistry, 2010, 1–5. doi: http://doi.org/10.1155/2010/478143

Downloads

Published

2020-08-31

How to Cite

Bezruk, I., Georgiyants, V., & Ivanauskas, L. (2020). Comparison of components profile in herbal raw material, extract and pharmaceuticals of Hedera Helix. ScienceRise: Pharmaceutical Science, (4 (26), 36–39. https://doi.org/10.15587/2519-4852.2020.210768

Issue

No. 4 (26) (2020)

Section

Pharmaceutical Science

License

Copyright (c) 2020 Ivan Bezruk, Victoriya Georgiyants, Liudas Ivanauskas

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.